Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR-12286 in Patients With Elevated Intraocular Pressure
NCT01060579Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Feb 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verosudil in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Feb 2010; status: completed.
02
Drugs
verosudil
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01060579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060579.